GV
Profile, fund size and portfolio
GV is Alphabet's venture capital arm. It invests from seed to growth across technology and life sciences. Alphabet is its only limited partner.
- AUM or capital under managementS1
- Over USD 13B
- Active companies, per the firmS1
- 400
- IPOs, per the firmS1
- 80
- M&A exits, per the firmS1
- 230+
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Seed to Growth |
| Sectors | Consumer, Enterprise: AI, security, infrastructure, Life sciences, Frontier technology |
| Geography | North America, Europe, Israel |
| Offices | Bay Area, New York, Cambridge, Massachusetts, London |
Sources: S1 GV, About page.
Data behind this graphic
| Item | Companies | Share |
|---|---|---|
| Active companies | 400 | 56.3% |
| M&A exits (230+) | 230 | 32.4% |
| IPOs | 80 | 11.3% |
Active companies, IPOs and M&A exits as the firm states them. Figures marked + are floors.
Sources: S1 GV, About page.
Data behind this graphic
| Measure | Value | Unit | Kind | Source |
|---|---|---|---|---|
| Headline size | Over USD 13B | AUM or capital under management | Stated by the firm or its parent | S1 |
| Names on portfolio page | 1,292 | companies | Counted from the firm's own list | S3 |
| Active companies, per the firm | 400 | companies | Stated by the firm | S1 |
| IPOs, per the firm | 80 | IPOs | Stated by the firm | S1 |
| M&A exits, per the firm (230 or more) | 230+ | exits | Stated by the firm | S1 |
Where it invests and who leads it
Geography
- Headquarters
- United States
- Offices
- Bay Area
- New York
- Cambridge, Massachusetts
- London
Investment regionsS1
- North America
- Europe
- Israel
LeadersS2
- David KraneCEO and Managing PartnerFind on LinkedInFirm page
- Dave MunichielloManaging PartnerFind on LinkedInFirm page
- Krishna YeshwantManaging PartnerFind on LinkedInFirm page
- Tom HulmeManaging PartnerFind on LinkedInFirm page
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Type | Corporate venture capital, one parent limited partner | Confirmed by two sources | S1 |
| Founded | 2009 | Single source | S1 |
| Headline size | Over USD 13B assets under management | Single source | S1 |
| Leader | David Krane, CEO and Managing Partner | Confirmed by two sources | S2 |
| Active portfolio companies | About 400 | Single source | S1 |
| IPOs reported by the firm | 80 | Single source | S1 |
| M&A exits reported by the firm | 230+ | Single source | S1 |
| Offices | Bay Area, New York, Cambridge (Massachusetts), London | Single source | S1 |
Overview
GV says it supports about 400 active portfolio companies across North America, Europe and Israel. It describes its edge as the stability of a single limited partner, the autonomy of a traditional venture firm and founder-level technical expertise.S1
Its own list of notable exits includes Uber, Nest, Slack, GitLab, Duo Security, Flatiron Health, Lemonade, Metsera, Modular, Verve Therapeutics and One Medical.S1
Parent company
Alphabet Inc. is listed on Nasdaq as GOOGL and GOOG and is based in Mountain View, California. GV describes itself as a venture fund that can invest in direct competitors of Google and has access to Google's people, products and reputation.S1
Fund size
GV does not raise outside funds. It agrees an annual pool with Alphabet. The 2012 and 2026 figures measure different things, so they should not be read as growth.S4
| Measure | Figure | Basis | Source |
|---|---|---|---|
| Launch commitment | USD 60M | GV website | S1 |
| Launch commitment, as recalled by David Krane in 2019 | USD 50M | Interview | S4 |
| Launch commitment, as given on Wikipedia | USD 100M | Secondary source | S3a |
| Annual pool and capital under management, 2012 | About USD 300M a year, USD 2B under management | Reuters, 8 Nov 2012, via Wikipedia | S3a |
| Capital under management, 2026 | Over USD 13B | Self-reported | S1 |
Stage and check size
GV invests from seed to growth.S1
Sectors and themes
Consumer, enterprise (AI, security, infrastructure), life sciences and frontier technology. GV Europe was described in March 2026 as about 80 percent AI.S1S6
Geographies and offices
Offices in the Bay Area, New York, Cambridge (Massachusetts) and London. Portfolio companies are in North America, Europe and Israel.S1
Portfolio
GV's portfolio page lists 1,292 names. About 400 are described as active.S1S3
Rounds GV has taken part in, from company releases, include Snorkel AI (USD 350M Series E, 22 Sep), Blacksmith (USD 45M Series B, 12 Aug), Odyssey (USD 310M Series B, 17 Jun), MokN (USD 15M Series A, 28 May) and Guild.ai (USD 44M, 3 Mar).S11
Every company on the GV list
646 companies, as listed on the firm's own website.S3 Read the firm's list.
- 23andMe
- 99 Counties
- Abacus
- About.me
- Acalvio
- Accent Therapeutics
- Adagio Therapeutics
- Adapter
- Adelphic Mobile
- Aera Therapeutics
- Affinia Therapeutics
- Again
- Agtonomy
- Ahana
- Air Protein
- Airtime
- Alector
- Aledade
- Alethea
- Alkira
- Allara Health
- Altana AI
- AltspaceVR
- Ambition
- AMP Robotics
- Anchor
- Andela
- AngelList
- Ankyra Therapeutics
- Anomali
- Antiva Biosciences
- Apptentive
- Apptimize
- Appurify
- Apteligent
- Arcus Biosciences
- Arda Therapeutics
- Areteia Therapeutics
- Armadin
- ARMO BioSciences
- Arrakis
- Arsanis
- Artifact
- Aspen Neuroscience
- Aspire Health
- Astrid
- Attio
- Autolus
- Basis
- BBOT
- Beacon Biosignals
- Beam Therapeutics
- Benson Hill
- Biomodal
- Bitterroot Bio
- Blacksmith
- BlackThorn Therapeutics
- Blavity
- Blockaid
- Blockchain
- Bloom Institute of Technology
- Blue Bottle Coffee
- Blue Vision Labs
- Blue Water Autonomy
- Bonnet
- Bounti
- Brightline
- Buena
- BufferBox
- Bugsnag
- Buoyant
- CacheFlow
- Cala Health
- Cambly
- Cameo
- Caraway Health
- Carbon
- Cardurion Pharmaceuticals
- CareBridge
- Career Karma
- Carmera
- Carnival Mobile
- Carrick Therapeutics
- Celsius Therapeutics
- Censys
- Cerevance
- Checkmate
- Checkr
- Chronosphere
- CircleUp
- CircuitHub
- Clarifai
- ClassPass
- Clear Labs
- ClearStory Data
- Clever
- Clever Care
- Climate-X
- CliQr Technologies
- Cloudera
- Clover Health
- Clutter
- Cmd
- Cockroach Labs
- Cognosys
- Cohesity
- Collaborate
- Collective Health
- Comanche Biopharma
- Comfy
- Compass Therapeutics
- Complyance
- Comstruct
- Confide
- Context.ai
- Continua
- Contraline
- Cool Planet
- Copper
- Cord
- Corduro
- CoreOS
- Cosmos
- Counsel Health
- Courier
- Cozy
- Crash Override
- creativeLIVE
- Crews By Core
- Cribl
- CTRL-labs
- Cur8
- Curie.Bio
- Currencycloud
- CyberGRX
- Cymbal
- Dandelion Energy
- Dapper Labs
- Dasient
- DataFox
- Datanyze
- Daydream
- dbt Labs
- Decibel Therapeutics
- Deepset
- Delighted
- Delphia Therapeutics
- Delve Bio
- Denali Therapeutics
- Desktop Metal
- Desmos
- Determined AI
- Devoted Health
- Dialpad
- Digit
- Digits
- Distance
- Diverge Health
- Divide
- DNAnexus
- Doctor On Demand
- DocuSign
- dope.security
- Doppler
- Driver
- DualEntry
- Duo Security
- Dyno Therapeutics
- EasyPost
- Editas Medicine
- Egnyte
- Element Science
- Emergent VR
- Emissary
- Encoded Therapeutics
- Endurosat
- English Central
- EpiBiologics
- EQRx
- Ethos
- Evelo Biosciences
- EveryONE Medicines
- Evident.io
- Evox Therapeutics
- Fabric
- Farmers Business Network
- Farmwise
- Fathom
- Firefly
- firsthand
- FitStar
- Flapping Airplanes
- Flatiron Health
- Flexport
- Flick
- Flock Freight
- Flourish
- FlutterFlow
- Forty Seven
- Found
- Foundation Medicine
- Framed
- Freenome
- Freshplum
- FullStory
- Fyto
- Gametime
- Gate Bioscience
- Genesis
- Genie AI
- Genome Medical
- Genomics Medicine Ireland
- Giphy
- GitLab
- Glass Imaging
- GoCardless
- Good Eggs
- Gowalla
- Graft
- Grail
- Granata Bio
- Granular
- Gravity
- Gravity Sketch
- Gritstone Bio
- Groundswell
- Guide Therapeutics
- Guidelight Health
- Guild.ai
- Gusto
- Gyft
- HAGS
- Happiest Baby
- Harness
- Harvey
- HeadSpin
- Headway
- HeartThis
- HEAVY.AI
- Hebbia
- Helium
- Helix
- HelloSign
- High Fidelity
- Highfive
- Hipster
- Home From College
- HomeAway
- Homebound
- HomeLight
- HOVER
- HubSpot
- humans&
- Hustle
- Hyperfine Research
- IconOVir Bio
- Ideaya Biosciences
- Imagen
- Impossible Foods
- Incorta
- Inertia
- Infinitus
- Insitro
- Instawork
- Intercom
- Invetx
- Ionic Security
- IonQ
- iPierian
- Isomorphic Labs
- Iterative Health
- Jaunt
- Jet
- Jetify
- JumpCam
- Kabam
- Kamcord
- Kensho
- Kindbody
- Kindred
- Kinetic Apps
- Kitchen United
- Kobalt
- Kronos Bio
- Lacework
- Lapse
- Lattice
- LaunchKit
- Laurel
- Lawhive
- LawPivot
- Layer Health
- LedgerX
- Lemonade
- LendUp
- LevelUp
- Leyden Labs
- LifeMine Therapeutics
- Lightmatter
- Lime
- Locker Room
- Lola
- Loom
- LotusFlare
- Lovevery
- Luminate
- Luminate Wireless
- Luna Park
- Luvocracy
- Luxe
- mabl
- Machinify
- Magenta Therapeutics
- Makani
- Managed by Q
- Matter
- Maze Therapeutics
- Mechanical Orchard
- Medallion
- Medium
- Merida Biosciences
- MessageMe
- Mestag Therapeutics
- Metabiota
- Metaview
- Metsera
- Midi Health
- Mighty AI
- Milk
- Mill
- Mimic
- MindMeld
- MindSumo
- MirrorTab
- Mirvie
- Mist Systems
- Mitro
- Mode
- Modern Age
- Modsy
- Modular
- Mohawk
- MokN
- Monte Rosa Therapeutics
- Monzo
- Moonhub
- Moonwalk Biosciences
- Mother Games
- Motive
- mParticle
- Multiverse
- myLaurel
- N3twork
- Namo Media
- Nanit
- Nava Benefits
- Nava Therapeutics
- nChroma Bio
- Nebex
- Nectar Social
- Neo.Tax
- Neo4j
- Nest
- Neuralink
- Nextbit
- Nextdoor
- Ngmoco
- Nimble
- Nimbus Therapeutics
- NoRedInk
- Nothing
- nPlan
- Nym Health
- Oasis Health Partners
- Oblenio Bio
- Obsidian Security
- Obsidian Therapeutics
- Odyssey
- OMass Therapeutics
- Omeat
- Omni Analytics
- Oncologic
- OnDeck
- One Medical
- oneNav
- Openbay
- Opendoor
- OpenEvidence
- Optimizely
- Optiwatt
- Oration
- Orbital Insight
- Oscar
- Osmo
- Oula Health
- Outdoor Voices
- Outlier
- Overture
- Overview
- OWKIN
- Oxford Science Enterprises
- Packagd
- PACT Pharma
- Pager
- Pangea
- Panorama Education
- Parabilis Medicines
- Paradigm Health
- Parsable
- Parse
- Partiful
- PatientPing
- PayRange
- Pecan AI
- Peerspace
- Pelage Pharmaceuticals
- Pensando
- PeopleOne Health
- Perceive Bio
- Percolata
- Periscope
- Periscope Data
- Phoebe
- Physna
- Pindrop
- Pixie Labs
- Plaid
- PlanGrid
- Plexxi
- Podium
- Polar Signals
- PostHog
- Poynt
- Premise
- Pretzel Therapeutics
- Prime Medicine
- Product Hunt
- Prudentia Sciences
- Puppet Labs
- Push Security
- Q.ai
- Q1
- Q2
- Quadratic
- Quartet
- Quettra
- Ramp
- Rani Therapeutics
- RAPT Therapeutics
- Rattle
- Reaction Commerce
- Recorded Future
- Recursive Superintelligence
- Redpanda
- Relay Therapeutics
- Republic Project
- Reserve
- Resilience
- Resistant AI
- Resolution Games
- RetailMeNot
- Revolution Medicines
- RhyGaze
- RightHand Robotics
- Rilla
- Ripcord
- Rippl Care
- Ripple Foods
- Ripple Labs
- Rise
- Robinhood
- Roboflow
- Rocana
- Rockbot
- Rocket Lawyer
- Rocketrip
- Rodin Therapeutics
- Roger
- ROME Therapeutics
- Rox
- SambaNova Systems
- Sana Biotechnology
- Sanas
- Santa Ana Bio
- Sardine
- Savioke
- Scalus
- Scalyr
- Scan
- Scandit
- Schematic Labs
- Schrödinger
- Science 37
- Scope3
- ScoutRFP
- Secret Escapes
- SecurityScorecard
- Segment
- Seismic Therapeutic
- Sense
- Sensorum Health
- Sesame
- Shape Security
- SideQuest
- Sierra
- Sift
- Signos
- Signpost
- Silver Spring Networks
- Simply
- SingleStore
- Skycatch
- Skyport Systems
- Slack
- Smarterer
- Smol
- Snorkel AI
- Snowball
- Snyk
- Sold
- SolveAI
- Sonoma Biotherapeutics
- Soylent
- Space Monkey
- Speakeasy
- SpeedyBrand
- Spero Therapeutics
- SpinLaunch
- Spring
- Sprinter Health
- Spruce Finance
- Spruce Health
- SpyBiotech
- SQZ Biotech
- StackBlitz
- StackOne
- Stamped
- StatusPRO
- Stipple Bio
- StockX
- Strella Biotechnology
- Stripe
- StrongDM
- Subtext
- SweetLabs
- Swell
- Swing Education
- Synack
- Synapticure
- Sync Labs
- Synthesia
- Syremis Therapeutics
- Tala
- Tamr
- Taysha Gene Therapies
- Teem
- Tenaya Therapeutics
- Tend
- Tennr
- TenSixteen Bio
- tenXer
- Tessl
- Thatch
- The Climate Corporation
- The Pill Club
- The Players' Tribune
- TheSkimm
- Thinking Machines Lab
- ThinkNear
- ThousandEyes
- TMRW Life Sciences
- Toast
- Trace Neuroscience
- Tracelytics
- Transcriptic
- Translucent AI
- Transphorm
- TravelJoy
- Treeline Biosciences
- TrueLens
- TScan Therapeutics
- TuneIn
- Turo
- Twyla
- Typeface
- Uber
- UberSense
- Udacity
- UJET
- Ultromics
- Unbabel
- Universe
- Upbound
- Upstart
- Upthere
- Urban Engines
- Urban Machine
- Ursa Computing
- URX
- Vaccitech
- Vareto
- Veem
- Ventus Therapeutics
- Veo Robotics
- Vera Therapeutics
- Verana Health
- Vercel
- Verse Enterprises
- Verve Therapeutics
- Veza
- Vicinitas Therapeutics
- VIDA
- VigLink
- Vir Biotechnology
- Vitara Biomedical
- Viz.ai
- Vocode
- Voicea
- Voltage
- Voltron Data
- Vungle
- Walker and Company
- Waltz Health
- Wander
- Warp
- Watch Club
- Waymo
- Wealth.com
- Weaveworks
- Wingu
- Witness AI
- Wonder
- Wonder Workshop
- Wonderbly
- Xilis
- Yellowbrick Data
- Yesware
- Yieldify
- Yieldmo
- Yuga Labs
- ZappRx
- Zencoder
- Zephyr Health
- Zest
- Zipline
Exits
GV reports 80 IPOs and more than 230 M&A exits. In January 2026 Apple agreed to acquire Q.ai, a GV portfolio company, and Ethos listed.S1S11
Co-investors and partnerships
GV co-led the EpiBiologics Series B (USD 107M) with JJDC.S11
Team
GV's team page lists about 100 people. Leaders shown include the following.S2
- David KraneCEO and Managing Partner
- Dave MunichielloManaging Partner
- Krishna YeshwantManaging Partner
- Tom HulmeManaging Partner
Investment activity
Global Corporate Venturing named GV second most active of 2025, with about 20 nine-figure rounds.S15
Contacting GV
GV publishes its team page. Founders can find the team at the official page linked below.S2
History
- Launches as Google Ventures with USD 60M, according to GV. First investments are Silver Spring Networks and Adimab.S1
- About USD 300M a year and USD 2B under management, per Reuters.S3a
- Opens a London office.S1
- Renamed GV after Alphabet is formed.S1S3a
- David Krane gives a ten-year interview and cites more than 600 deals.S4
- Apple agrees to acquire Q.ai. Ethos lists.S11
What different sources say
- Launch size: GV gives USD 60M, David Krane recalled USD 50M in 2019, and Wikipedia cites USD 100M from a 2009 press item.S1S3aS4
- Size today: GV says over USD 13B in assets under management. Wikipedia says about USD 10B.S1S3a
- Portfolio count: the portfolio page lists 1,292 names and describes about 400 as active. These count different things.S1S3
Common questions
Official pages
Read the firm's own pages for current information.
Sources
- S1GV, About pageFirm
- S2GV, Team pageFirm
- S3GV, Portfolio page and newsFirm
- S3aWikipedia, GV (company)Reference
- S4TechCrunch Disrupt SF interview with David Krane, October 2019Press
- S6MediaPost, 20 March 2026Press
- S9Aranca, Quarterly Spotlight: Corporate Venture Capital Deal Analysis, Q2 2026 (PitchBook data)Third-party report
- S11Company releases and press, 2026 (Snorkel AI 22 Sep, Blacksmith 12 Aug, Odyssey 17 Jun; Axios, TechCrunch, Reuters on Q.ai)Press
- S15Global Corporate Venturing, most active corporate investors of 2025Press
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by GV or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.